期刊文献+

小鼠慢性移植物抗宿主病荷瘤模型的建立 被引量:2

Establishment of Chronic Graft-versus-host Disease Mice Bearing Leukemia Model
暂未订购
导出
摘要 目的通过供鼠淋巴细胞输注诱导小鼠慢性GVHD,并在此基础上荷瘤建立慢性GVHD的GVL模型,为研究慢性GVHD和GVL作用奠定基础。方法以雄性BALB/c(H-2d)为供鼠,雌性CB6F1(BALB/c×C57BL/6 F1,H-2d/b)为受鼠,通过尾静脉输注8×107/个脾细胞诱导小鼠慢性移植物抗宿主病,在输注25天后,受鼠随机分组,通过尾静脉或腹腔或皮下方式接种P815肿瘤细胞,构建慢性GVHD荷瘤模型,用于研究慢性GVHD的同时研究GVT作用。结果 3种荷瘤方式均可形成荷瘤。尾静脉方式可形成小鼠白血病模型,符合人类疾病特点,成功构建慢性GVDH荷瘤的GVL模型。结论成功建立小鼠慢性移植物抗宿主病荷瘤模型。 Objective Induce murine model of chronic GVHD after donor lymphocyte infusion. In order to study GVL effect at the same time inoculation of tumor cells after transplantation. Methods Male BALB/c( H - 2d) mice were used as donors and female CB6F1 (BALB/c × C57BL/6 F1 ,H- 2d/b) mice as recipients. 8 x 107of spleen cells by tail vein injection to induce murine model of chronic graft- versus- host disease,in experiments meant to study graft- versus- leukemia (GVL) activity, select groups of CB6F1 recipients were injected intraperitoneally (i. p. ) or subcutaneous or intravenous (i. v. ) 25 days after transplantation with P815 tumor cells. Results These three methods all can established the P815 tumor- bearing mice model. Tail vein approach is more in line with characteristics of human disease,the GVL model was established successfully by intraparitoneal injection. Conclusion successfully established of cGVHD mice bearing leukemia model.
出处 《医学研究杂志》 2013年第5期86-90,共5页 Journal of Medical Research
基金 浙江省自然科学基金资助项目(Y2101069)
关键词 慢性移植物抗宿主病 移植物抗白血病作用 小鼠 chronic graft - versus - host disease graft - versus - leukemia effect mice
  • 相关文献

参考文献14

  • 1吴远彬,郭坤元,陆志刚,周健,宋朝阳,吴秉毅,吴顺杰.单倍体相合造血干细胞移植后慢性移植物抗宿主病小鼠模型的建立及其评价[J].中国组织工程研究与临床康复,2008,12(12):2326-2330. 被引量:7
  • 2Anderson BE,Mcniff JM,Jain D,et al. Distinct roles for donor - and host - derived antigen - presenting cells and costimulatory molecules in murine chronic graft - versus - host disease : requirements depend on target organ[ J]. Blood, 2005. 105(5) :2227 - 2234.
  • 3Baird K, Pavletic SZ. Chronic graft versus host disease [ J ]. Curr Opin Hematol,2006 ,13(6) :426 - 435.
  • 4Van Burik JA, Carter SL,Freifeld AG,et al. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell - depleted unrelated bone marrow : analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft - versus - host disease[ J]. Biol Blood Marrow Transplant, 2007,13 (12) :1487 -1498.
  • 5Marktel S, Magnani Z, Cicer F, et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T - cell - depleted stem cell transplantation [ J ]. Blood,2003 ,101(9) : 1290 - 1298.
  • 6Tsirigotis P,0r R,Resnick IB,ef al. Immunotherapeutic approaches to improve graft - versus - tumor effect and reduce graft - versus - host disease[ J]. Immunotherapy f 2012 ,4(4) :407 -424.
  • 7Lee SJ. Have we made progress in the management of chronic graft - vs -host disease? [ J ] . Best Pract Res Clin Haematol, 2010 , 23 (4): 529 -535.
  • 8Hubbard VM , Eng JM , Ramirez - Montagut T ,et al. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation[ J]. Blood, 2005,106 (9) : 3285 -3292.
  • 9Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor F0XP3 -positive regulatory T - cell ( Treg) content is associated with a low risk of GVHD following HLA - matched allogeneic SCT[ J]. Blood, 2006, 108(4) : 1291 -1297.
  • 10Liang Y,Liu C,Dieu JY,ei al. Beta2 integrins separate graft - versus -host disease and graft - versus - leukemia effects[ J]. Blood, 2008 , 111(2) :954 -962.

二级参考文献20

  • 1邓兰,郭坤元,尹晓林,李玉华,吴岚晓.MHC半相合骨髓移植后慢性GVHD小鼠模型的建立[J].免疫学杂志,2005,21(4):306-308. 被引量:6
  • 2Joffre O,van Meerwijk JP. CD4(+)CD25(+) regulatory T lymphocytes in bone marrow transplantation. Semin Immunol 2006; 18(2): 128-135
  • 3Kaplan DH, Anderson BE, McNiff JM, et al. Target antigens determine graft-versus-host disease phenotype. J Immunol 2004; 173(5): 5467-5475
  • 4Anderson BE, McNiff JM, Jain D, et al. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005; 105(5): 2227-2234
  • 5Matte CC, Liu J, Cormier J, et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004; 10(9): 987-992
  • 6Anderson BE, McNiff JM, Matte C, et al. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 2004;104(5):1565-1573
  • 7Alpdogan O, Eng JM, Muriglan SJ, et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005;105(2):865-873
  • 8Hamilton BL,Parkman R. Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice. Transplantation 1983; 36(2): 150-155
  • 9Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease. J Immunol 1987;139(6):1840-1849
  • 10Hakim FT, Sharrow SO, Payne S, et al. Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes. J Immunol 1991;146(7):2108-2115

共引文献6

同被引文献21

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部